Core Nursing Explanation
Key Concept Analysis: This question assesses the recognition and priority nursing intervention for
Acute Graft-versus-Host Disease (aGVHD). aGVHD is a severe, potentially fatal complication following an allogeneic hematopoietic stem cell transplant (HSCT). It occurs when donor T-cells (the graft) recognize the recipient's tissues (the host) as foreign and mount an immune attack. The classic triad involves the skin, gastrointestinal (GI) tract, and liver, as seen in this patient: fever, maculopapular rash (skin), severe diarrhea (GI), and elevated liver enzymes (liver). The timing (post-transplant day +14) is also classic for acute GVHD.
Answer Rationale:
Key Point! The nurse's priority is to
notify the physician immediately and
implement strict isolation precautions. aGVHD is a medical emergency requiring prompt diagnosis and initiation of high-dose immunosuppressive therapy (e.g., corticosteroids) to halt the immune attack. Furthermore, the patient is profoundly immunocompromised from the transplant and the impending immunosuppressive treatment. Strict isolation (often protective or neutropenic precautions) is critical to prevent life-threatening secondary infections, which are the leading cause of mortality in these patients.
Distractor Analysis:
•
Watch out for confusion! Option ① (Administer broad-spectrum antibiotics) is incorrect because the fever and symptoms are most likely due to the immune-mediated process of GVHD, not a primary bacterial infection. Empiric antibiotics might be considered later if infection is suspected, but the priority is to address the root cause—GVHD.
• Option ② (Increase fluid intake and monitor electrolytes) addresses a
supportive need. Severe diarrhea leads to fluid and electrolyte imbalances, which are important to manage. However, this is a secondary intervention that follows the priority of notifying the physician to treat the underlying GVHD.
• Option ④ (Apply topical corticosteroids) is incorrect. While topical steroids may be part of skin GVHD management, the systemic involvement (GI and liver) indicated by diarrhea and elevated enzymes (
ALT 180 U/L, AST 165 U/L vs.
Normal ~7-56 U/L) necessitates
systemic treatment. Applying a topical cream does not address the life-threatening systemic condition.
Related Concepts: The nursing process dictates that life-threatening conditions (like aGVHD) and infection prevention in immunocompromised hosts take precedence over supportive measures. Understanding the pathophysiology of GVHD (donor vs. host) is key to differentiating it from other post-transplant complications like infection or organ toxicity.
Concept Summary
•
Acute Graft-versus-Host Disease (aGVHD): Immune attack by donor cells on recipient organs (skin, GI, liver). Peak onset: 2-6 weeks post-transplant.
•
Classic Triad: Rash (often starting on palms/soles), diarrhea, elevated liver function tests (LFTs).
•
Priority Nursing Actions: 1. Immediate physician notification. 2. Implement infection control/isolation. 3. Prepare for/administer immunosuppressive therapy.
•
Supportive Care: Fluid/electrolyte replacement, skin care, nutritional support—all are important but follow the primary interventions.
Side-by-Side Comparison!
| Complication | Typical Onset | Key Features | Priority Nursing Focus |
|---|
| Acute GVHD | Weeks 2-6 post-transplant | Triad: Rash, watery diarrhea, jaundice/elevated LFTs; Fever | Notify MD, isolation, prepare for immunosuppression |
| Engraftment Syndrome | During neutrophil recovery | Fever, rash, non-cardiogenic pulmonary edema (capillary leak) | Supportive care (O2, diuretics), monitor respiratory status |
| Veno-occlusive Disease (VOD/SOS) | First 3 weeks post-transplant | Triad: Painful hepatomegaly, jaundice, fluid retention/weight gain | Fluid balance management, pain control, monitor for renal failure |
Anatomy, Physiology & Pharmacology Points
•
Pathophysiology: Donor T-cells (CD4+, CD8+) recognize host HLA (Human Leukocyte Antigen) differences → release cytokines (TNF-α, IL-1) → tissue damage in skin (basal layer), intestinal crypts, and bile ducts.
•
Pharmacology: First-line treatment is high-dose corticosteroids (e.g., methylprednisolone). Second-line agents include calcineurin inhibitors (tacrolimus), mTOR inhibitors (sirolimus), or monoclonal antibodies.
•
Lab Values: Elevated ALT (Alanine Aminotransferase) and AST (Aspartate Aminotransferase) indicate hepatocellular injury from liver GVHD. Bilirubin will also rise as disease progresses.
Memory Tips
• Acronym for GVHD Organs: Skin, Gut, Liver = SGL (Think: "Seriously Gut-wrenching Liver problem").
• Timing: Acute GVHD happens in the first 100 days. Chronic GVHD occurs after 100 days.
• Priority Action: Think "Isolation and Immunosuppression" for "Immediate" intervention.
High-Frequency NCLEX Topics
NCLEX loves testing priority and delegation. In an immunocompromised patient with new, systemic symptoms, the priority is always to assess, notify, and protect. Recognizing the pattern of GVHD and knowing that it requires urgent medical (not just nursing) intervention is a high-yield concept for oncology and transplant nursing questions.
Watch Out for Question Variations!
• Instead of asking for the priority intervention, the question might ask: "Which finding is most indicative of acute GVHD?" (Answer: The combination of rash + diarrhea + elevated LFTs).
• It could shift to pharmacology: "The physician orders methylprednisolone. The nurse understands this is for which purpose?" (Answer: To suppress the immune response causing GVHD).
• Or focus on patient education: "What should the nurse teach the patient to report immediately after discharge?" (Answer: Any new rash, diarrhea, or yellowing of skin/eyes).